Skip to main content
    O

    Ocugen Inc (OCGN)

    Official site

    HEALTHCARE ā€¢ BIOTECHNOLOGY ā€¢ NASDAQ

    $0.81
    -0.03 (-3.27%)

    Market Cap: $285.26M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    46%(18/39)
    Avg Surprise
    -34.21%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.05
    Range$-0.07 - $-0.04
    3 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.050.0%
    60d ago$-0.05-2.5%
    30d ago$-0.050.0%
    7d ago$-0.050.0%
    Current$-0.05
    Revenue Consensus
    $780000
    Range$0 - $2M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.08
    Range$-0.11 - $-0.02
    3 analysts
    Revenue Consensus
    $3M
    Range$994030 - $4M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.08---
    Sep 26EST
    		-$-0.05---
    Jun 26
    Reported Aug 6
    		$-0.07$-0.05-40.00%Miss-40.0%
    Mar 26
    Reported May 5
    		$-0.06$-0.05-20.00%Miss-20.0%
    Dec 25
    Reported Mar 4
    		$-0.06$-0.06-7.14%Miss-20.0%
    Sep 25
    Reported Nov 5
    		$-0.07$-0.06-16.67%Miss-40.0%
    Jun 25
    Reported Aug 1
    		$-0.05$-0.06+16.67%Beat-25.0%
    Mar 25
    Reported May 9
    		$-0.05$-0.06+16.67%Beat+0.0%
    Dec 24
    Reported Mar 5
    		$-0.05$-0.05+6.19%Beat-66.7%
    Sep 24
    Reported Nov 8
    		$-0.05$-0.05+0.00%Beat+16.7%
    Jun 24
    Reported Aug 8
    		$-0.04$-0.05+20.00%Beat+60.0%
    Mar 24
    Reported May 13
    		$-0.05$-0.06+16.67%Beat+28.6%
    Dec 23
    Reported Mar 26
    		$-0.03$-0.06+50.00%Beat+70.0%
    Sep 23
    Reported Nov 9
    		$-0.06$-0.07+14.29%Beat+40.0%
    Jun 23
    Reported Aug 21
    		$-0.10$-0.07-42.86%Miss-11.1%
    Mar 23
    Reported May 5
    		$-0.07$-0.11+36.36%Beat+22.2%
    Dec 22
    Reported Feb 28
    		$-0.10$-0.10+0.00%Beat-42.9%
    Sep 22
    Reported Nov 8
    		$-0.10$-0.10+0.00%Beat-100.0%
    Jun 22
    Reported Aug 5
    		$-0.09$-0.08-12.50%Miss+30.8%
    Mar 22
    Reported May 6
    		$-0.09$0.01-776.69%Miss-125.0%
    Dec 21
    Reported Feb 25
    		$-0.07$-0.07+0.00%Beat-133.3%
    Sep 21
    Reported Nov 9
    		$-0.05$-0.04-25.00%Miss+28.6%
    Jun 21
    Reported Aug 6
    		$-0.13$-0.03-333.33%Miss+31.6%
    Mar 21
    Reported May 7
    		$-0.04N/A-110.00%Miss+42.9%
    Dec 20
    Reported Mar 18
    		$-0.03$-0.02-50.00%Miss-100.7%
    Sep 20
    Reported Nov 6
    		$-0.07$-0.02-250.00%Miss+98.0%
    Jun 20
    Reported Aug 14
    		$-0.19$-0.04-375.00%Miss-58.3%
    Mar 20
    Reported May 8
    		$-0.07$-0.05-40.00%Miss+98.5%
    Dec 19
    Reported Mar 27
    		$4.13$-0.14+3050.00%Beat+162.6%
    Sep 19
    Reported Nov 12
    		$-3.55$-0.60-491.67%Miss+75.3%
    Jun 19
    Reported Aug 9
    		$-0.12$-0.01-1100.00%Miss+98.5%
    Mar 19
    Reported May 15
    		$-4.80$-0.60-700.00%Miss+84.6%
    Dec 18
    Reported Mar 22
    		$-6.60$-3.60-83.33%Miss+57.7%
    Sep 18
    Reported Nov 8
    		$-14.40$-12.20-18.03%Miss-4.3%
    Jun 18
    Reported Aug 9
    		$-7.80$-14.00+44.29%Beat+48.0%
    Mar 18
    Reported May 10
    		$-31.20$-13.20-136.36%Miss-92.6%
    Dec 17
    Reported Mar 15
    		$-15.60$-16.20+3.70%Beat+58.1%
    Sep 17
    Reported Nov 9
    		$-13.80$-16.92+18.44%Beat-
    Jun 17
    Reported Aug 10
    		$-15.00$-18.15+17.36%Beat-
    Mar 17
    Reported May 11
    		$-16.20$-20.70+21.74%Beat-
    Dec 16
    Reported Mar 16
    		$-37.20$-27.00-37.78%Miss-

    Key Metrics

    Valuation
    P/E Ratio-3.13EV/EBITDAN/A
    Price/FCF-4.52xFCF Yield-22.14%
    Profitability
    Profit Margin0.00%Operating Margin-1105.00%
    ROE-660.00%ROIC385.96%
    Financial Health
    Debt/Equity-0.11xInterest Coverage-6.68x
    Current Ratio0.80xQuick Ratio0.80x
    Trading Statistics
    Beta2.27Avg Volume7.24M
    52-Week High$2.7352-Week Low$0.79

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.95
    SMA 20$0.99
    SMA 50$1.16
    SMA 200$1.47
    EMA 10$0.93
    EMA 20$0.99
    EMA 50$1.11
    EMA 200$1.32

    MACD

    Line: -0.08Signal: -0.07Hist: -0.01

    ADX

    ADX: 24.3+DI: 12.8-DI: 33.9

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down96.0
    PSAR$1.04

    Bollinger Bands

    Upper Band$1.13
    Lower Band$0.85
    %B Position2880%(Upper)
    Band Width-0.12

    RSI (14-Day)

    Oversold
    24.8

    Momentum Oscillators

    Stoch %K10.5
    Stoch %D14.3
    Williams %R-91.4
    ROC (10d)-18.6%
    Momentum-0.19
    CCI (20d)-223.8
    MFI (14d)28.1

    Volatility Measures

    ATR (14d)$0.07(8.8%)
    StdDev (20d)0.07
    Hist Vol51.0%(High)

    Volume Flow

    VWAP$0.82
    OBV-30.7M
    AD Line-299.7M
    CMF (20d)-0.229

    Volume Metrics

    Avg Vol (20d)7.3M
    Vol Ratio0.8x
    VWMA (20d)$0.99

    Pivot Points

    R3$1.05
    R2$0.98
    R1$0.91
    Pivot Point$0.85
    S1$0.78
    S2$0.71
    S3$0.64

    Advanced Oscillators

    TSI-33.83
    Ultimate Osc36.4
    KST-178.55

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.49M$1.53M$-193,000$1.75M$1.37M$1.48M$764,000$1.14M$1.14M$1.01M$1.41M$3.70M
    Cost of Revenue$0$0N/A$0$0$0$598,000$0$0$0$179,000$0
    Gross Profit$1.49M$1.53M$-193,000$1.75M$1.37M$1.48M$764,000$1.14M$1.14M$1.01M$1.41M$3.70M
    Operating Expenses$17.93M$19.37M$16.80M$19.38M$15.17M$15.98M$14.60M$14.39M$16.59M$13.23M$12.93M$16.13M
    R&D$10.69M$11.26M$10.67M$11.15M$8.40M$9.53M$8.29M$8.11M$8.90M$6.83M$7.78M$7.05M
    SG&A$7.24M$8.12M$6.13M$8.23M$6.77M$6.45M$6.31M$6.28M$7.69M$6.40M$5.16M$9.08M
    Operating Income$-16,444,000$-17,839,000$-16,995,000$-17,625,000$-13,795,000$-14,501,000$-13,840,000$-13,252,000$-15,449,000$-12,216,000$-11,525,000$-12,431,000
    Interest Income$395,000$132,000$2.69M$207,000$227,000$343,000$466,000$310,000$173,000$302,000$0$0
    Interest Expense$6.86M$1.32M$532,000$1.31M$1.28M$1.26M$54,000$29,000$0$0$0$0
    Income Before Tax$-24,877,000$-19,177,000$-17,527,000$-20,051,000$-14,739,000$-15,350,000$-13,894,000$-12,970,000$-15,276,000$-11,914,000$-11,525,000$-12,431,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-24,877,000$-19,177,000$-17,706,000$-20,051,000$-14,739,000$-15,350,000$-13,880,000$-12,970,000$-15,280,000$-11,924,000$-10,970,000$-11,717,000
    EBITDA$-15,911,000$-17,022,000$-17,392,000$-17,994,000$-12,754,000$-13,527,000$-13,242,000$-12,638,000$-14,871,000$-12,037,000$-11,346,000$-12,254,000
    EBIT$-18,413,000$-17,989,000$-16,995,000$-18,944,000$-13,681,000$-14,436,000$-13,840,000$-13,251,000$-15,449,000$-12,216,000$-11,525,000$-12,431,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OCGN

    OCGN Valuation and Fair Value

    P/E
    -3.1x
    Forward P/E
    13.1x
    P/FCF
    -4.5x
    P/B
    -16.6x
    See GNG's fair value

    OCGN Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    -1105.0%
    Net margin
    0.0%
    ROIC
    386.0%
    ROE
    -660.0%
    FCF margin
    -1332.4%
    FCF yield
    -22.1%

    OCGN Competitors

    CompanyTicker
    Movano IncMOVE
    Fulcrum Therapeutics IncFULC
    QuantumSi IncQSI
    Surrozen IncSRZN
    Contineum Therapeutics, Inc. Class A Common StockCTNM
    Anika Therapeutics IncANIK
    Indaptus Therapeutics IncINDP
    InfuSystems Holdings IncINFU

    Sector: Healthcare

    OCGN Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    1
    Buy
    5
    Hold
    0
    Sell
    0
    Strong Sell
    0

    OCGN Bull Case vs Bear Case

    Bull case

    • OCGN earns a 386.0% return on invested capital.
    • 100.0% of OCGN's analyst ratings are Buy or Strong Buy.

    Bear case

    • OCGN beat EPS estimates in 37.5% of its last 8 reported quarters.

    OCGN Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -5.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.05
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About OCGN

    Does OCGN pay dividends?

    Ocugen Inc (OCGN) does not currently pay a regular dividend.

    What is OCGN's market cap?

    Ocugen Inc (OCGN) has a market capitalization of $285.26M with a current stock price of $0.81.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In